RecruitingNot ApplicableNCT06725459

NPWT Reduction Mammaplasty

Assessing the Application of Closed Incision Negative Pressure Wound Therapy to Reduction Mammaplasty

Sponsor

Medstar Health Research Institute

Enrollment

92 participants

Start Date

Dec 17, 2024

Study Type

INTERVENTIONAL

Conditions

Healthy Mammaplasty Wound Healing Macromastia Negative Pressure Therapy

Summary

In this prospective, randomized, split-body control trial, we aim to compare complications, patient-reported outcomes, and cost differentials following reduction mammaplasty with prophylactic closed incision negative pressure wound therapy versus standard adhesive dressing.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Prophylactic ciNPWT and Standard Adhesive Dressing for people with healthy, macromastia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEProphylactic ciNPWT

The prophylactic closed incision negative pressure wound therapy (ciNPWT) will be applied to one breast for up to 7 days postoperatively to promote wound healing and prevent complications.

OTHERStandard Adhesive Dressing

The standard adhesive strip dressing will be applied to one breast immediately after surgery. It provides a protective covering for the wound during the initial healing phase and is the standard of care for incision management.